<DOC>
	<DOCNO>NCT00449410</DOCNO>
	<brief_summary>In elderly patient atrial fibrillation ( AF ) presence silent brain infarct neurocognitive deficit high despite adequate treatment oral anticoagulation . Atherosclerosis consider chronic inflammatory disease thrombosis inflammation strongly correlate . Atrial fibrillation link increased level inflammatory marker intensive cholesterol lower proven reduce inflammation . In prospective double-blind randomize pilot-study want test hypothesis , addition intensive cholesterol lower treatment besides adequate oral anticoagulation reduce cerebrovascular lesion beneficial neurocognitive status elderly AF patient .</brief_summary>
	<brief_title>Silent Cerebrovascular Lesion Cognitive Decline Prevention Cholesterol Lowering Elderly AF Patients</brief_title>
	<detailed_description />
	<mesh_term>Inflammation</mesh_term>
	<mesh_term>Atrial Fibrillation</mesh_term>
	<mesh_term>Cerebrovascular Disorders</mesh_term>
	<mesh_term>Atorvastatin Calcium</mesh_term>
	<mesh_term>Ezetimibe</mesh_term>
	<criteria>Elderly patient ( &gt; 68 &lt; 82 year ) atrial fibrillation adequate oral anticoagulation therapy cholesterol level 4,5 mmol/l 7 mmol/l Indication cholesterol lower treatment accord Dutch CBOcholesterol guideline ( 2004 )</criteria>
	<gender>All</gender>
	<minimum_age>68 Years</minimum_age>
	<maximum_age>82 Years</maximum_age>
	<verification_date>March 2007</verification_date>
	<keyword>Atrial Fibrillation</keyword>
	<keyword>elderly</keyword>
	<keyword>cholesterol lower</keyword>
	<keyword>neurocognitive function</keyword>
	<keyword>cerebrovascular lesion</keyword>
</DOC>